Vergho, Daniel; Kneitz, Susanne; Rosenwald, Andreas; Scherer, Charlotte; Spahn, Martin; Burger, Maximilian; Riedmiller, Hubertus; Kneitz, Burkhard (2014). Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC cancer, 14, p. 25. BioMed Central 10.1186/1471-2407-14-25
|
Text
Spahn_BMC Cancer_14_25_Combination of expression levels.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (866kB) | Preview |
BACKGROUND
Renal cell carcinoma (RCC) is marked by high mortality rate. To date, no robust risk stratification by clinical or molecular prognosticators of cancer-specific survival (CSS) has been established for early stages. Transcriptional profiling of small non-coding RNA gene products (miRNAs) seems promising for prognostic stratification. The expression of miR-21 and miR-126 was analysed in a large cohort of RCC patients; a combined risk score (CRS)-model was constructed based on expression levels of both miRNAs.
METHODS
Expression of miR-21 and miR-126 was evaluated by qRT-PCR in tumour and adjacent non-neoplastic tissue in n = 139 clear cell RCC patients. Relation of miR-21 and miR-126 expression with various clinical parameters was assessed. Parameters were analysed by uni- and multivariate COX regression. A factor derived from the z-score resulting from the COX model was determined for both miRs separately and a combined risk score (CRS) was calculated multiplying the relative expression of miR-21 and miR-126 by this factor. The best fitting COX model was selected by relative goodness-of-fit with the Akaike information criterion (AIC).
RESULTS
RCC with and without miR-21 up- and miR-126 downregulation differed significantly in synchronous metastatic status and CSS. Upregulation of miR-21 and downregulation of miR-126 were independently prognostic. A combined risk score (CRS) based on the expression of both miRs showed high sensitivity and specificity in predicting CSS and prediction was independent from any other clinico-pathological parameter. Association of CRS with CSS was successfully validated in a testing cohort containing patients with high and low risk for progressive disease.
CONCLUSIONS
A combined expression level of miR-21 and miR-126 accurately predicted CSS in two independent RCC cohorts and seems feasible for clinical application in assessing prognosis.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology |
UniBE Contributor: |
Spahn, Martin |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1471-2407 |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Katharina Morgenegg |
Date Deposited: |
27 Feb 2015 08:42 |
Last Modified: |
05 Dec 2022 14:41 |
Publisher DOI: |
10.1186/1471-2407-14-25 |
PubMed ID: |
24428907 |
BORIS DOI: |
10.7892/boris.63516 |
URI: |
https://boris.unibe.ch/id/eprint/63516 |